Effect of botulinum toxin concentration on reduction in sweating: a randomized, double-blind study

Area of Science:

• Dermatology
• Aesthetic Medicine
• Pharmacology

Background:

• Dose-response data for botulinum toxin in hyperhidrosis treatment is limited.
• Optimizing botulinum toxin concentrations can enhance treatment efficacy and safety.
• Understanding concentration-dependent effects is crucial for cost-effective therapeutic strategies.

Purpose of the Study:

• To identify the optimal concentrations of Botox, Dysport, Xeomin, and NeuroBloc for maximal sweat reduction.
• To establish dose conversion ratios between different botulinum toxin formulations.
• To inform clinical practice regarding the appropriate use of botulinum toxins for hyperhidrosis.

Main Methods:

• A randomized, double-blind, placebo-controlled study involving 20 subjects.
• Intradermal injections of four concentrations of Botox, Dysport, Xeomin, and NeuroBloc on the back.
• Assessment of anhidrotic and hypohidrotic areas using the iodine-starch test at 4, 8, and 12 weeks.

Main Results:

• Optimal concentrations: 25 U/ml (Botox, Xeomin), ~100 U/ml (Dysport), 50 U/ml (NeuroBloc).
• Dose conversion ratios (per unit at 100 U/ml): 1:1.6:1.2:1.3 (Botox:Dysport:Xeomin:NeuroBloc).
• Dose conversion ratios (at optimal concentrations): 1:4.8:1.3:2.2 (Botox:Dysport:Xeomin:NeuroBloc).

Conclusions:

• Botulinum toxin concentration significantly impacts treatment outcomes for sweating reduction.
• Different botulinum toxin products require distinct optimal concentrations for efficacy.
• Establishing concentration-response relationships is vital for safe and cost-effective hyperhidrosis management.